Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(50%)
Terminated
1(50%)

Phase Distribution

Ph phase_2
1
50%
Ph phase_3
1
50%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (50.0%)
Phase 31 (50.0%)

Trials by Status

recruiting150%
terminated150%

Recent Activity

1 active trials
Showing 2 of 2
recruitingphase_2

Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage

NCT04696523
terminatedphase_3

Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

NCT01155310

Clinical Trials (2)

Showing 2 of 2 trials
NCT04696523Phase 2

Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage

Recruiting
NCT01155310Phase 3

Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Terminated

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2